Human genome is so cheap after earnings today and glaxo has a huge partnership with them. i belive that the buyout will be announce in the next 2 weeks at a price of 18-20 pps
What are the advantages or disadvantages for current HGSI shareholders also owning GSK should a !6$ buyout take place?
Good call. Now what's your take in gsk's next move?
GSK will walk away, just like YHOO's refusal to be bought by MSFT.